ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Ratos Ab (PK)

Ratos Ab (PK) (RTOBF)

3.42
0.00
( 0.00% )
Actualizado: 14:32:15

Ratos Ab (PK) (RTOBF) Cotización

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
3.42
( - )
Postura de Compra
3.25
Postura de Venta
3.59
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
3.42 Rango de 52 semanas 3.99
Capitalización de Mercado [m]
Precio Anterior
3.42
Precio de Apertura
-
Hora
Última hora de negociación
-
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
US$ 362,524
Acciones en circulación
327,385,688
Rendimiento del Dividendo (LTM)
1.4 (4.24%)
Ratio Precio/Utilidad
-12.33
Beneficio por acción (BPA)
6.24
turnover
19.09B
Beneficio neto
2.08B

Acerca de Ratos Ab (PK)

Ratos AB (publ) is a private equity firm specializing in buyouts, turnarounds, add on acquisitions, and middle market transactions. The firm does not invest in early stages and in companies that operate in the arms industry, pornography, or are detrimental to the environment. It seeks to invest in u... Ratos AB (publ) is a private equity firm specializing in buyouts, turnarounds, add on acquisitions, and middle market transactions. The firm does not invest in early stages and in companies that operate in the arms industry, pornography, or are detrimental to the environment. It seeks to invest in unlisted medium sized companies. The firm invests in industry and technology (including aftermarket information and training solutions, sustainable core material development, product and digital service development at the intersection between business strategy and technological development, secondary optics, camping and outdoor equipment, third-party logistics, and contract research for biotech and pharmaceutical companies,) construction and services (including electrification of rail infrastructure, maintenance of critical transportation infrastructure, technology and design of complex sustainable energy solutions, and Construction of commercial properties, public buildings and housing), consumer (including plants, flowers and related products) sectors. The firm typically invests in the Nordic region, with focus on Sweden, Finland, Denmark, and Norway. It seeks to invest in companies with equity investments between SEK250 million ($27.20 million) and SEK5000 million ($543.99 million), sales value between SEK300 million ($32.64 million) and SEK5000 million ($543.99million) and EBITDA greater than SEK50 million ($5.43 million). The firm takes both minority and majority stakes. The firm prefers to be the principal owner with a minimum holding of at least 20 percent and also seeks a board seat. It prefers to hold its investment between five to ten years. Ratos AB (publ) was founded in 1866 and is based in Stockholm, Sweden. Mostrar más

Sector
Finance
Industria
Asset Management Services
Sitio web
Sede
Stockholm, Sweden
Fundado
1866
Ratos Ab (PK) is listed in the Finance sector of the OTC Markets with ticker RTOBF. The last closing price for Ratos Ab (PK) was US$3.42. Over the last year, Ratos Ab (PK) shares have traded in a share price range of US$ 3.42 to US$ 3.99.

Ratos Ab (PK) currently has 327,385,688 shares in issue. The market capitalisation of Ratos Ab (PK) is US$1.12 billion. Ratos Ab (PK) has a price to earnings ratio (PE ratio) of -12.33.

RTOBF Últimas noticias

No hay noticias para mostrar aún.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000CS
4003.423.423.4213203.42CS
12-0.57-14.28571428573.993.993.4232203.89515528CS
26-0.18-53.63.993.4217933.89439148CS
52-0.18-53.63.993.428573.89439148CS
1560.3069.826589595383.1143.993.11422523.60173904CS
260-0.22-6.043956043963.646.193.11419723.58177449CS

RTOBF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ratos Ab (PK)?
El precio actual de las acciones de Ratos Ab (PK) es US$ 3.42
¿Cuántas acciones de Ratos Ab (PK) están en circulación?
Ratos Ab (PK) tiene 327,385,688 acciones en circulación
¿Cuál es la capitalización de mercado de Ratos Ab (PK)?
La capitalización de mercado de Ratos Ab (PK) es USD 1.12B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ratos Ab (PK)?
Ratos Ab (PK) ha negociado en un rango de US$ 3.42 a US$ 3.99 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ratos Ab (PK)?
El ratio precio/beneficio de Ratos Ab (PK) es -12.33
¿Cuál es el ratio de efectivo a ventas de Ratos Ab (PK)?
El ratio de efectivo a ventas de Ratos Ab (PK) es 0.57
¿Cuál es la dirección registrada de Ratos Ab (PK)?
La dirección registrada de Ratos Ab (PK) es Sturegatan 10, Stockholm, Stockholm County, 114 36
¿Cuál es la dirección del sitio web de Ratos Ab (PK)?
La dirección del sitio web de Ratos Ab (PK) es www.ratos.com/en/
¿En qué sector industrial opera Ratos Ab (PK)?
Ratos Ab (PK) opera en el sector Asset Management Services

RTOBF Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
delerious1 delerious1 4 minutos hace
Buy/Sell Ratio
Buy: 30,595,296..........Neutral: 135,000...........Sell: 6,788,497
FITY
Just give me $1.50 Just give me $1.50 4 minutos hace
The Mikah Scam.

Can't expose himself to the big boys on the Nasdaq.

If a company with Elite’s numbers has a stock price in the 0.30s, and they chose to stay on the OTC, then questions have to be asked why .
ELTP
Chartmaster Chartmaster 4 minutos hace
Nope, the chart doesn't show that, however the chart was super bullish here and I made the most money here than any other ticker, see the results
https://investorshub.advfn.com/uimage/uploads/2021/10/27/xrxxqnsav_378k.PNG
NSAV
dexprs dexprs 5 minutos hace
Sold VSCO on the pop.
ed3/6me ed3/6me 5 minutos hace
Grabbed on fri. @26. Washappy....but....darn!
CAPR
LuLa LuLa 5 minutos hace
Cyberlux Corporation ($CYBL) has emerged from an 18-month period of malicious, adversarial litigation that has suppressed cash and revenue. With the Texas turnover receiver terminated by court order, the company is now focused fully on business again.

From late 2024 through mid-2026,
CYBL
i_like_bb_stock i_like_bb_stock 7 minutos hace
CGTL took some got another 180 days extension https://dilution.news/7c54a14976124a9a4c4a1481e39ead6e
CGTL
Lsmith500 Lsmith500 7 minutos hace
https://x.com/suntexcorp/status/2071677508739801276?s=46
SNTX
Chartmaster Chartmaster 7 minutos hace
34K is the target price after it broke the 80k neckline support of the massive H&S topping pattern, you take the 126k high, minus the 80k neckline equals 46k, then subtract that 46k from the 80k neckline projects to 34k, so simple
BTCUSD
i_like_bb_stock i_like_bb_stock 7 minutos hace
CGTL took some got another 180 days extension https://dilution.news/7c54a14976124a9a4c4a1481e39ead6e
CGTL
floblu14 floblu14 7 minutos hace
Another Russell addition -

Enanta Pharmaceuticals, Inc.(NasdaqGS:ENTA) added to Russell 3000E Growth Benchmark
Published on 06/29/2026 at 12:08 am EDT

https://www.marketscreener.com/news/enanta-pharmaceuticals-inc-nasdaqgs-enta-added-to-russell-3000e-growth-bench
ENTA
Lime Time Lime Time 8 minutos hace
Yep. At rock bottom, cant go wrong here 🚀
CBGL
VVVVVV VVVVVV 8 minutos hace
Wrong again, ignorance is bliss.

They were issuing press releases for years that never came to fruition. This is when the statute if limitations more than likely would have started. IMHO.

Remember little man, “ should have known”, they would have not reported”. Beca
VDRM
imafan imafan 8 minutos hace
End of the week 2¢,5¢,10¢...or higher? BOOM!!!
HHSE
Trooperstocks Trooperstocks 8 minutos hace
$NICH is quietly hitting every critical milestone:
💰Audit nearing completion: Finalizing a comprehensive two-year audit with a PCAOB-registered firm.
🌐Restoring transparency: Actively working to regain full regulatory reporting status.
✅Disciplined capital all
NICH
Trooperstocks Trooperstocks 8 minutos hace
$NICH is quietly hitting every critical milestone:
💰Audit nearing completion: Finalizing a comprehensive two-year audit with a PCAOB-registered firm.
🌐Restoring transparency: Actively working to regain full regulatory reporting status.
✅Disciplined capital all
NICH
rosemountbomber rosemountbomber 8 minutos hace
I envy guys like you, Kiwi, and others who are connoisseurs and can readily differentiate between various wines. Maybe it is a skill that can be developed through practice. I, unfortunately, like Mark Cuban, couldn't tell the difference between a $5 bottle and a $500 bottle of wine. Now, others t
UNCY
sweet crude sweet crude 8 minutos hace
Quantum Stocks: $QBTS $RGTI $IONQ $QUBT

Stock research in the quantum stock sector, investor conferences.

https://quantummeow.com/newsletter/
IONQ QBTS QUBT
doccjc doccjc 9 minutos hace
Don’t be fooled. He doesn’t own shares.  He just owns shares in a competitor of RDGL. Those bashing own zero shares collectively. An Approval should clean up the board . 
RDGL
art2426 art2426 10 minutos hace
It's amazing isn't it? An investment in a company that has never had a profitable year in over 20 years selling product. Has total liabilities of what they OWE of $18,083,918 with assets of what they OWN of only $142,362. Total sales for the year 2025 of $510,623 with current liabilities due in o
BIEL
Danielle LA TRADRICK Danielle LA TRADRICK 10 minutos hace
Space x is just fine I brought 152 again up a lot ba k to 200s
SPCX
The_Edge The_Edge 11 minutos hace
Patience
CBGL
tradelodge tradelodge 11 minutos hace
There was a purchase of 198,888 shares at .0075 this morning. 
GRLF
Trooperstocks Trooperstocks 11 minutos hace
$AIMN @AimwellPartners enters the $100B+ RegTech market with the launch of AimwellBio. As healthcare becomes the fastest-growing vertical in regulatory tech, Aimwell is building the "trust layer" for AI in medicine.

🔹 Solving the 47% AI error rate in medical advice.
&#x
AIMN

Su Consulta Reciente

Delayed Upgrade Clock